JavaScript is disabled in your browser. Please enable JavaScript to view this website.
AB176750

Apoptosis/ Necrosis Assay Kit (blue, red, green)

5

(1 Review)

|

(19 Publications)

Apoptosis/ Necrosis Assay Kit (blue, red, green) (ab176750) is designed to simultaneously monitor apoptotic, necrotic and healthy cells.
1 Images
Fluorescence Microscopy - Apoptosis/ Necrosis Assay Kit (blue, red, green) (AB176750)
  • Fluorescence Microscopy

Supplier Data

Fluorescence Microscopy - Apoptosis/ Necrosis Assay Kit (blue, red, green) (AB176750)

Detection of binding activity of Apopxin Deep Red Indicator to phosphatidylserine in Jurkat cells using Apoptosis/Necrosis Detection Kit (blue, red, green) (ab176749).

The fluorescence image shows cells that are live (blue, stained by CytoCalcein Violet 450), apoptotic (red, stained by Apopxin Deep Red Indicator), and necrotic (green, indicated by Nuclear Green DCS1staining) in Jurkat cells induced by 1μM staurosporine for 3 hours. The fluorescence images of the cells were taken with a fluorescence microscope through the Violet, Cy5 and FITC channel respectively. Individual images taken from each channel from the same cell population were merged as shown above. A : Non-induced control cells; B : Triple staining of staurosporine-induced cells.

Key facts

Sample types

Suspension cells, Adherent cells

Assay type

Cell-based

Assay time

1h

Assay Platform

Flow cytometer, Fluorescence microscope

Product details

Apoptosis/ Necrosis Assay Kit (blue, red, green) (ab176750) is designed to simultaneously monitor apoptotic, necrotic and healthy cells.

The PS sensor used in this kit has red fluorescence (Ex/Em = 630/660 nm) upon binding to membrane PS.

Loss of plasma membrane integrity, as demonstrated by the ability of the membrane-impermeable DNA Nuclear Green DCS1 dye (Ex/Em = 490/525 nm) to label the nucleus, represents a straightforward approach to demonstrate late stage apoptosis and necrosis.

This apoptosis / necrosis assay also provides a live cell cytoplasm labeling dye CytoCalcein Violet 450 (Ex/Em = 405/450 nm) to label live cell cytoplasm.

This kit is optimized to simultaneously detect cell apoptosis (Red), apoptosis (red and/or green) and healthy cells (blue) with a flow cytometer or fluorescence microscope.

This product was previously called Apoptosis/ Necrosis Detection Kit.

What's included?

{ "values": { "100Test": { "sellingSize": "100 Test", "publicAssetCode":"ab176750-100Test", "assetComponentDetails": [ { "size":"1 x 50 mL", "name":"Assay Buffer", "number":"AB176750-CMP02", "productcode":"" }, { "size":"1 x 1 Vial", "name":"CytoCalcein Violet 450", "number":"AB176750-CMP03", "productcode":"" }, { "size":"1 x 100 µL", "name":"Nuclear Green DCS1 Dye", "number":"AB176750-CMP04", "productcode":"" }, { "size":"1 x 200 µL", "name":"Apopxin Deep Red Indicator", "number":"AB176750-CMP01", "productcode":"" } ] } } }

Properties and storage information

Shipped at conditions
Blue Ice
Appropriate short-term storage conditions
-20°C
Appropriate long-term storage conditions
-20°C
Storage information
-20°C

Supplementary information

This supplementary information is collated from multiple sources and compiled automatically.

Apoptosis and necrosis are distinct forms of cell death with mechanical and biological differences. Apoptosis is a highly regulated process often called programmed cell death while necrosis is an uncontrolled cell death resulting from injury or infection. Apoptosis involves a series of signaling pathways including the activation of caspases a family of proteases that play essential roles in cell death. The apoptotic process takes place in various tissues and is important for maintaining cellular homeostasis. Necrosis on the other hand typically occurs due to acute damage and is characterized by cell swelling membrane rupture and inflammation. These processes can be investigated using tools like apoptosis detection kits and necrosis markers.
Biological function summary

Apoptosis serves to eliminate damaged or unnecessary cells without eliciting an inflammatory response. It is part of the intrinsic and extrinsic pathways that incorporate various proteins and signaling molecules. During apoptosis the formation of complexes such as the apoptosome triggers caspase activation. Key players in apoptosis also include Bcl-2 family proteins which regulate mitochondrial membrane permeability. Conversely necrosis results in a direct inflammatory response due to the release of intracellular contents. Both apoptosis and necrosis play roles in developmental processes and maintaining tissue integrity.

Pathways

The apoptotic process integrates into pathways like the mitochondrial (intrinsic) pathway and the death receptor (extrinsic) pathway. In the intrinsic pathway cytochrome c release from mitochondria forms the apoptosome complex with Apaf-1 and caspase-9 leading to downstream caspase activation. The extrinsic pathway involves death receptors such as Fas and TNF receptor interacting with adaptor proteins to activate caspase-8. Necrosis typically results from pathophysiological conditions but can share overlaps with necroptosis a regulated form of necrosis involving proteins such as RIPK1 and RIPK3.

Dysregulation of apoptosis and necrosis is linked to conditions like cancer and neurodegenerative diseases. Abnormal apoptosis is associated with cancer where reduced apoptosis allows uncontrolled cell proliferation. This often involves proteins such as p53 which can promote apoptosis under stress conditions but mutations can alter its function. In neurodegenerative diseases like Alzheimer's both apoptosis and necrosis contribute to neuronal loss. The accumulation of misfolded proteins like amyloid-beta may trigger apoptotic pathways while necrosis can result from oxidative stress and excitotoxicity.

Product protocols

Target data

Publications (19)

Recent publications for all applications. Explore the full list and refine your search

ACS central science 10:2294-2311 PubMed39735314

2024

Cyclic Ruthenium-Peptide Prodrugs Penetrate the Blood-Brain Barrier and Attack Glioblastoma upon Light Activation in Orthotopic Zebrafish Tumor Models.

Applications

Unspecified application

Species

Unspecified reactive species

Liyan Zhang,Gangyin Zhao,Trevor Dalrymple,Yurii Husiev,Hildert Bronkhorst,Gabriel Forn-Cuní,Bruno Lopes-Bastos,Ewa Snaar-Jagalska,Sylvestre Bonnet

Advanced science (Weinheim, Baden-Wurttemberg, Germany) 11:e2404355 PubMed38900068

2024

Injectable biodegradable microcarriers for iPSC expansion and cardiomyocyte differentiation.

Applications

Unspecified application

Species

Unspecified reactive species

Annalisa Bettini,Patrizia Camelliti,Daniel J Stuckey,Richard M Day

International journal of molecular sciences 24: PubMed37762608

2023

Cerium Oxide Nanoparticles Protect Cortical Astrocytes from Oxygen-Glucose Deprivation through Activation of the Ca Signaling System.

Applications

Unspecified application

Species

Unspecified reactive species

Elena G Varlamova,Alexey S Baryshev,Sergey V Gudkov,Valentina A Babenko,Egor Y Plotnikov,Egor A Turovsky

International journal of molecular sciences 24: PubMed37569591

2023

Pilot Study of Cytoprotective Mechanisms of Selenium Nanorods (SeNrs) under Ischemia-like Conditions on Cortical Astrocytes.

Applications

Unspecified application

Species

Unspecified reactive species

Elena G Varlamova,Egor Y Plotnikov,Ilya V Baimler,Sergey V Gudkov,Egor A Turovsky

Journal of the American Chemical Society 145:14963-14980 PubMed37379365

2023

Cyclic Ruthenium-Peptide Conjugates as Integrin-Targeting Phototherapeutic Prodrugs for the Treatment of Brain Tumors.

Applications

Unspecified application

Species

Unspecified reactive species

Liyan Zhang,Peiyuan Wang,Xue-Quan Zhou,Ludovic Bretin,Xiaolong Zeng,Yurii Husiev,Ehider A Polanco,Gangyin Zhao,Lukas S Wijaya,Tarita Biver,Sylvia E Le Dévédec,Wen Sun,Sylvestre Bonnet

Cancers 15: PubMed37345155

2023

Single Fraction and Hypofractionated Radiation Cause Cochlear Damage, Hearing Loss, and Reduced Viability of Merlin-Deficient Schwann Cells.

Applications

Unspecified application

Species

Unspecified reactive species

Christine T Dinh,Si Chen,Aida Nourbakhsh,Kyle Padgett,Perry Johnson,Stefania Goncalves,Olena Bracho,Esperanza Bas,Jorge Bohorquez,Paula V Monje,Cristina Fernandez-Valle,Nagy Elsayyad,Xuezhong Liu,Scott M Welford,Fred Telischi

eLife 10: PubMed34951591

2021

De novo synthesized polyunsaturated fatty acids operate as both host immunomodulators and nutrients for .

Applications

Unspecified application

Species

Unspecified reactive species

Thomas Laval,Laura Pedró-Cos,Wladimir Malaga,Laure Guenin-Macé,Alexandre Pawlik,Véronique Mayau,Hanane Yahia-Cherbal,Océane Delos,Wafa Frigui,Justine Bertrand-Michel,Christophe Guilhot,Caroline Demangel

International journal of molecular sciences 22: PubMed34204001

2021

Radiodynamic Therapy Using TAT Peptide-Targeted Verteporfin-Encapsulated PLGA Nanoparticles.

Applications

Unspecified application

Species

Unspecified reactive species

Sandhya Clement,Ayad G Anwer,Layla Pires,Jared Campbell,Brian C Wilson,Ewa M Goldys

Haematologica : PubMed32855276

2020

Combinatorial molecule screening identifies a novel diterpene and the BET inhibitor CPI-203 as differentiation inducers of primary acute myeloid leukemia cells.

Applications

Unspecified application

Species

Unspecified reactive species

Simon Hultmark,Aurélie Baudet,Ludwig Schmiderer,Pavan Prabhala,Sara Palma-Tortosa,Carl Sandén,Thoas Fioretos,Rajkumar Sasidharan,Christer Larsson,Sören Lehmann,Gunnar Juliusson,Fredrik Ek,Mattias Magnusson

Nature metabolism 2:934-945 PubMed32719542

2020

Genome-scale in vivo CRISPR screen identifies RNLS as a target for beta cell protection in type 1 diabetes.

Applications

Unspecified application

Species

Unspecified reactive species

Erica P Cai,Yuki Ishikawa,Wei Zhang,Nayara C Leite,Jian Li,Shurong Hou,Badr Kiaf,Jennifer Hollister-Lock,Nese Kurt Yilmaz,Celia A Schiffer,Douglas A Melton,Stephan Kissler,Peng Yi
View all publications
websiteProtocolBooklet
en

Product promise

We are committed to supporting your work with high-quality reagents, and we're here for you every step of the way. In the unlikely event that one of our products does not perform as expected, you're protected by our Product Promise.
For full details, please see our Terms & Conditions

Please note: All products are 'FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC OR THERAPEUTIC PROCEDURES'.

For licensing inquiries, please contact partnerships@abcam.com